Aneurysm Coiling and Embolization Devices Market to Grow by USD 2.0 Billion from 2025-2029, Driven by Rising IAS Cases and AI-Powered Market Evolution - Technavio

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global aneurysm coiling and embolization devices market size is estimated to grow by USD 2.0 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 8.1% during the forecast period. Increasing prevalence of ias and associated risk factors is driving market growth, with a trend towards growing demand for flow diversion as alternative to neurovascular coiling. However, high cost of treatment poses a challenge. Key market players include Acandis GmbH, Asahi Intecc Co. Ltd., B.Braun SE, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson Inc., Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., and Terumo Corp..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Market Driver

The Aneurysm Coiling and Embolization Devices market is experiencing significant growth due to the increasing prevalence of neurovascular illnesses such as ischemic strokes, aneurysms, and arteriovenous malformations. Early detection and treatment are key to mitigating cognitive disability and neurological illnesses. Neurosurgeons are turning to endovascular therapy, including aneurysm clips and liquid embolic agents, for efficient neurovascular device solutions. Technological advancements like shield technology and intrasaccular devices are driving product approvals and commercialization. Emerging revenue pockets include the treatment of fistulas and stenosis. Import and export analysis, production analysis, and value chain optimization are essential for market success. Key players include those specializing in embolic coils, bare detachable coils, and neurovascular embolization devices. Medical reimbursements and continued technological innovations will continue to shape the market landscape. 

The management of intracranial aneurysms (IAs) with complex morphologies has historically presented challenges using traditional surgical clipping procedures. These methods have been linked to significant risks of morbidity and mortality. Alternative endovascular techniques such as Stent-Assisted Coiling (SAC) and Balloon-Assisted Coiling (BAC) have also shown suboptimal efficacy due to high rates of recanalization. In response, there has been a shift towards flow diversion procedures, which offer a lower complication rate, higher cure rate, and increased safety. These advantages, along with reduced chances of re-aneurysm formation, shorter recovery periods, and lower radiation exposure, make flow diversion an attractive option for IA treatment. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

• The global market for Aneurysm Coiling and Embolization Devices is witnessing significant growth due to the increasing prevalence of neurovascular illnesses, such as ischemic strokes, aneurysms, arteriovenous malformations, and fistulas. Early detection and treatment of these conditions are crucial to prevent cognitive disability and neurological illnesses. Neurosurgeons rely on embolization devices like aneurysm clips, liquid embolic agents, and intrasaccular devices for endovascular therapy. Technological advancements, including shield technology and bare detachable coils, offer improved efficiency and safety. Product approvals and commercialization of neurovascular embolization devices continue to drive market revenue. Import and export analysis, production analysis, and medical reimbursements are key factors influencing market growth. Emerging revenue pockets include the treatment of stenosis and vascular diseases. Optimizing the value chain and addressing healthcare infrastructure challenges are essential for market success.
• The market for aneurysm coiling and embolization devices is significant, yet the high costs associated with these treatments limit their adoption. In the US, the one-year cost for a patient with an intracranial aneurysm (IA) treated by clipping averages around USD42,000, while the cost for neuroendovascular coiling for a patient with a ruptured IA is approximately USD45,000. Patients may also incur additional expenses for angiograms, complications, and adverse effects. Coil prices range from USD500 to USD3,000, depending on thickness, length, and features. A stent used in Subarachnoid Hemorrhage (SAC) treatment costs around USD5,000 to USD5,500. These costs can present a challenge for healthcare providers and patients alike.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview

This aneurysm coiling and embolization devices market report extensively covers market segmentation by

1. Product
• 1.1 Embolization coils
• 1.2 Access and delivery services
• 1.3 Aneurysm clips
• 1.4 Balloon and stent assisted coils
• 1.5 Flow diversion devices
2. Geography
• 2.1 North America
• 2.2 Europe
• 2.3 Asia
• 2.4 Rest of World (ROW)

1.1 Embolization coils- Endovascular coiling, also known as endovascular embolization or coiling, is a minimally invasive procedure used to treat aneurysms by filling the sac with material that seals it off and reduces the risk of bleeding. Indicated for intracranial aneurysms (IAs) and other neurovascular abnormalities, coiling is less invasive than surgical clipping, resulting in shorter hospitalization and recovery times. In developed markets, six to seven out of ten patients undergo coiling procedures. Two types of coils are available: Guglielmi Detachable Coils (GDC) and matrix coils. GDC, a bare platinum coil soldered to a stainless steel delivery wire, is the gold standard due to its flexibility and simple release mechanism. Matrix coils, coated with bioactive agents, aim to induce a healing response and improve filling volume, but have not yet shown statistically significant results regarding satisfactory occlusion rate and clinical outcome. Factors driving the growth of the endovascular coiling and embolization devices market include the rising number of procedures, patient preference for minimally invasive surgeries, and technological advances.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

The Aneurysm Coiling and Embolization Devices market refers to the segment of the medical industry focused on the production and distribution of devices used in the treatment of neurological conditions, particularly cerebrovascular diseases such as brain aneurysms and vascular malformations. These devices, which include coils and embolization materials, are used in minimally invasive procedures like endovascular neurosurgery to prevent the rupture of aneurysms and promote neurological recovery. Neurological assessment plays a crucial role in identifying the need for treatment, while brain imaging and neurological rehabilitation are essential components of the care process. Brain health awareness is increasing, leading to a growing demand for advanced neurological care to prevent stroke and manage neurological complications from vascular abnormalities. Neurovascular devices are transforming brain health by enabling effective brain surgery and improving neurological outcomes for patients, reducing physical disability and enhancing overall brain health.

Market Research Overview

The Aneurysm Coiling and Embolization Devices Market encompasses a range of medical devices used in the treatment of neurovascular illnesses, including aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. Early detection and timely intervention are crucial in managing these conditions, which can lead to cognitive disability or even death. Technological advancements have led to the development of various devices such as intrasaccular devices, liquid embolic agents, and bare detachable coils. Neurosurgeons and neurovascular specialists utilize these devices in endovascular therapy, which involves the use of shield technology to minimize complications. Aneurysms, cerebral aneurysms, and neurovascular diseases are among the key conditions treated with these devices. Product approvals and technological innovations continue to drive market growth, with emerging revenue pockets in healthcare infrastructure development and import-export analysis. Efficient neurovascular devices, embolic coils, and neurovascular embolization devices are essential in optimizing value chain operations and addressing neurovascular conditions like stenosis, fistulas, and vascular diseases. Neurological illnesses and medical reimbursements also play a significant role in market dynamics.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Product
• Embolization Coils
• Access And Delivery Services
• Aneurysm Clips
• Balloon And Stent Assisted Coils
• Flow Diversion Devices
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio